Table 3.

Longitudinal Sensitivity Changes^*

FCP Examination	Region	FU1	FU2	FU3
Mesopic	RPD	−3.68 ± 0.46 dB	−7.19 ± 0.50 dB	−7.76 ± 0.51 dB
		(P < 0.0001)	(P < 0.0001)	(P < 0.0001)
	New RPD	−1.89 ± 0.72 dB	−4.76 ± 0.72 dB	−5.97 ± 0.70 dB
		(P = 0.0096)	(P < 0.0001)	(P < 0.0001)
	Non-RPD	−2.63 ± 0.59 dB	−4.63 ± 0.59 dB	−3.12 ± 0.59 dB
		(P < 0.0001)	(P = 0.0004)	(P < 0.0001)
Scotopic	RPD	−1.18 ± 0.72 dB	−3.50 ± 0.73 dB	−3.51 ± 0.74 dB
		(P = 0.1166)	(P < 0.0001)	(P < 0.0001)
	New RPD	−0.48 ± 0.83 dB	−2.55 ± 0.83 dB	−2.06 ± 0.82 dB
		(P = 0.569)	(P = 0.0039)	(P = 0.0168)
	Non-RPD	−0.23 ± 0.77 dB	−0.57 ± 0.77 dB	0.32 ± 0.77 dB
		(P = 0.7612)	(P = 0.4654)	(P = 0.6800)

^*Estimate ± standard error deriving from a regression model at each follow-up (FU) visit of mesopic and scotopic FCP testing in regions with RPD, new arising regions of RPD (New RPD), and unremarkable regions of RPD (Non-RPD) corresponding to Figure 4 with longitudinal P values (follow-up visit to baseline visit).